Pfizer, Inverness Agree To Work Together On Digital e.p.t. Pregnancy Test
This article was originally published in The Gray Sheet
Executive Summary
Pfizer soon will sell a digital version of its e.p.t. pregnancy test kit under an agreement with Inverness Medical Innovations allowing the drug firm to use patented technology from Inverness' Clearblue Easy Digital product
You may also be interested in...
Inverness Will Develop Home-Use Heart Test At Scottish R&D Facility
ITI Life Sciences, a Scottish economic and business development initiative, will provide Inverness Medical Innovations with $57 mil. through 2008 to help identify novel biomarkers for near-patient and home-use cardiovascular disease tests
Inverness Will Develop Home-Use Heart Test At Scottish R&D Facility
ITI Life Sciences, a Scottish economic and business development initiative, will provide Inverness Medical Innovations with $57 mil. through 2008 to help identify novel biomarkers for near-patient and home-use cardiovascular disease tests
Inverness’ $92.5 Mil. Abbott Rapid Testing Buy Could Return TestPack To U.S.
Abbott Labs will retain exclusive distribution rights for the TestPack and Signify test lines in the U.S., while the products' new owner - Inverness Medical Innovations - will take on international distribution responsibilities